Concepedia
Statistics
Publications
28
Citations
2.1K
H-Index
20
Active since
1984
Affiliations
Abbott Fund(Current)
Abbott (United Kingdom)
Abbott (United States)
Immunosciences Lab (United States)
Health Canada
Louise M. Dubé is an author at Abbott Fund specializing in clinical pharmacology, zileuton therapy, and pharmacology.
Publications per year
1984–2007
Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
Jeffrey M. Drazen, Chandri Yandava, Louise M. Dubé et al. · Nature Genetics · 1999 · 566 citations
Medicine, Genetics, Molecular Genetics +6
Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics
Barbro Dahlén, Ewa Niżankowska, A Szczeklik et al. · American Journal of Respiratory and Critical Care Medicine · 1998 · 395 citations
Pharmacy, Pharmacology, Pharmacotherapy +14
Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: A 6-month randomized multicenter trial
Mark C. Liu, Louise M. Dubé, James Lancaster · Journal of Allergy and Clinical Immunology · 1996 · 248 citations · Full text
Clinical Predictors of Health-related Quality of Life Depend on Asthma Severity
Marilyn L. Moy, Elliot Israel, Scott T. Weiss et al. · American Journal of Respiratory and Critical Care Medicine · 2001 · 182 citations · Full text
Pharmacy, Pharmacotherapy, Health Assessment +16
Anti-inflammatory Effects of Zileuton in a Subpopulation of Allergic Asthmatics
Jeffrey D. Hasday, Susan S. Meltzer, Wendy C. Moore et al. · American Journal of Respiratory and Critical Care Medicine · 2000 · 68 citations
Life Sciences, Immunology, Pharmacology +16
1–5 of 28